1											2														3
								4
																							5
				6
			7														8
9
		10																	11
12
13																					14
														15			16
							17
		18
19		20
											21
								22
						23

Across 2. the major sites of action of this are the heart, respiratory tract, GI tract, urinary bladder, eye and endocrine glands 6. when there is a very small difference between therapeutic and toxic dosages 7. anticholinergics are used in treatment of ______ and GI hypersecretory states 9. populations who are more sensitive to these include infants, children with Down syndrome, with spastic paralysis, brain damage and the elderly 10. anticholinergics relaxes ______ in the bronchi and bronchioles 13. another name for anticholinergics 17. drug allergy, angle-closure glaucoma, acute asthma or other respiratory distress, myasthenia gravis, acute cardiovascular instability, and GI/GU obstruction/illness 18. paralysis of the ocular lens 19. dilation of the pupil 21. the antipsycotic effects of this drug are reduced with taken with cholingergic blockers 22. used primarily in the management of cardiovascular disorders such as sinus node dysfuntion 23. encourage patient to wear these due to increased sensitivity to light

Down 1. in the respiratory tract cholingergic blockers results in ______ secretions from the nose, mouth, pharynx and bronchi 3. one of the oldest groups of therapeutic drugs 4. proven very effective in removing from the GI tract any drug that hasn't been absorbed 5. cholinergic blockers have a therapeutic effect on this system by decreasing muscle rigidity and reduce tremors 8. anticholinergics slow the heart rate at ____ doses 11. at high dosages cholinergic blockers block the _____ ____ effects on the pacemaker cells of the SA and AV nodes, accelerating heart rate 12. exercise must be done with caution due to the risk of this happening with anticholingergics 14. cholingergic blockers are used ______________ to reduce salivary secretions 15. cholingergic blockers are used to treat disorders of the GU tract such as _____ 16. cholinergic blocking drugs blocks the action of this neurotransmitter 20. the effects of this drug are increased when taken with anticholingergics